H.C. Wainwright upgraded Bionomics to Buy from Neutral with an $8 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BNOX:
- William Blair reiterates Outperform on Bionomics after ‘significant win’
- Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
- Bionomics reports ‘positive’ results from Phase 2b ATTUNE trial of BNC210
- Bionomics provides update on Merck collaboration
- Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD